Association of Regulatory Affairs professionals (ARAP) and The Organization for Professionals in Regulatory Affairs (TOPRA), the leading professionals associations focused on supporting regulatory affairs professionals working in the Pharmaceuticals as well as Medical Devices industry, are collaborating to facilitate this inter-regulatory conference to address recent changes introduced by Indian as well as European Regulator. Association of Regulatory Affairs professionals (ARAP) in collaboration with The Organization of Professionals Regulatory Affairs (TOPRA) and cooperation from The European Federation of Pharmaceutical Industries and Associations (EFPIA) organize two days conference named ‘Indian and European Regulatory &amp; Quality Summit 2019 (IERQS)’. The theme of the conference is “Thriving in a Globalised Regulatory Environment” which will ignite young minds in searching a novel approach towards the sensations of sustainable future in regulatory affairs. IERQS will bring together representatives of the European and Indian medicinal and medical device authorities, policy analysts and industry professionals to discuss unclear areas and uncover practical implementation solutions that address the implications of the new requirements.
IERQS 2019 holds the agenda to address all the unexplored questions, create promising opportunities and build foolproof strategies to embark the success stories through meaningful partnerships. The conference aims to work on exceptional ideas which will not only lead to an innovative ecosystem but also help in forming an addressee global network of enthusiastic leaders, professionals and educators.
This International meet anticipates hundreds of delegates including Keynote speakers, Oral presentations by renowned speakers
The first day of the conference will review and discuss the changes in Indian requirements. The second day of the conference is dedicated to address European requirements for clinical trials, orphan drugs, FMD etc,.
All the Discussions at the summit will be captured in one white paper that will be offered as input to the Indian Authorities and European Authorities to support consistent interpretation and implementation of the new regulatory requirements.